España
India
Italia
대한민국
日本
My Account
My Account
Notifications
Overview
+ New Watchlist
Benzinga Research
Benzinga Pro
Log In
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Get Benzinga Pro
Data & APIs
Events
Marketfy
Premarket
Boost
Advertise
Contribute
España
India
Italia
대한민국
日本
Sign in
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Government
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Cryptocurrency
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Credit Cards
Crypto
Cannabis
Cannabis Conference
News
Earnings
Interviews
Deals
Regulations
Psychedelics
Jobs
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Reviva Pharmaceuticals
RVPH
NASDAQ
Watchlist
Get Report
Perks
Buy
Compare Brokers
$1.22
-0.02
-1.61%
At Close: -
$1.15
-0.07
-5.74%
After Hours: 7:28 PM EDT
15 minutes delayed
Get Report
Watch
Reviva Pharmaceuticals (RVPH) Forecast
News
Earnings
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Reviva Pharmaceuticals (NASDAQ:RVPH) Stock
Reviva Pharmaceuticals Stock (NASDAQ: RVPH)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, July 11, 2024
HC Wainwright & Co. Reiterates Buy on Reviva ...
Benzinga Newsdesk
Tuesday, July 09, 2024
Reviva Granted A European Patent Covering The...
Benzinga Newsdesk
Thursday, June 20, 2024
HC Wainwright & Co. Reiterates Buy on Reviva ...
Benzinga Newsdesk
Tuesday, June 11, 2024
HC Wainwright & Co. Maintains Buy on Reviva P...
Benzinga Newsdesk
Tuesday, May 28, 2024
Benchmark Reiterates Speculative Buy on Reviv...
Benzinga Newsdesk
Reviva Announces $3M Registered Direct Offeri...
Benzinga Newsdesk
Wednesday, May 15, 2024
Reviva Provides Enrollment Update For Its Ope...
Benzinga Newsdesk
Tuesday, May 14, 2024
Reviva Pharmaceuticals Q1 EPS $(0.25) Beats $...
Benzinga Newsdesk
Monday, May 13, 2024
Reviva To Present New Preclinical Efficacy Da...
Benzinga Newsdesk
Thursday, May 09, 2024
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
Monday, April 22, 2024
HC Wainwright & Co. Reiterates Buy on Reviva ...
Benzinga Newsdesk
Tuesday, April 16, 2024
Benchmark Reiterates Speculative Buy on Reviv...
Benzinga Newsdesk
Monday, April 15, 2024
Reviva Pharmaceuticals Q4 EPS $(0.35) Misses ...
Benzinga Newsdesk
Reviva Announces Alignment With FDA On Brilar...
Benzinga Newsdesk
Thursday, March 28, 2024
Reviva To Present RECOVER Phase 3 Clinical Tr...
Benzinga Newsdesk
Tuesday, March 26, 2024
Reviva Pharmaceuticals Holdings shares are tr...
Benzinga Newsdesk
Reviva to Present RECOVER Phase 3 Clinical Tr...
Benzinga Newsdesk
Monday, March 25, 2024
HC Wainwright & Co. Reiterates Buy on Reviva ...
Benzinga Newsdesk
Tuesday, February 20, 2024
HC Wainwright & Co. Reiterates Buy on Reviva ...
Benzinga Newsdesk
Tuesday, February 06, 2024
Reviva to Host KOL Event To Discuss Topline D...
Benzinga Newsdesk
Thursday, January 04, 2024
Reviva Provides Corporate And Program Updates...
Benzinga Newsdesk
Tuesday, December 26, 2023
HC Wainwright & Co. Reiterates Buy on Reviva ...
Benzinga Newsdesk
Friday, December 22, 2023
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga Insights
Monday, December 18, 2023
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga Insights
Thursday, November 16, 2023
Reviva Announces $30M Registered Direct Offer...
Benzinga Newsdesk
Wednesday, November 15, 2023
Reviva Pharmaceuticals Board Member Awarded $45K Worth of Stock Options
Benzinga Insights
Tuesday, November 14, 2023
Reviva Pharmaceuticals Q3 EPS $(0.44) Misses ...
Benzinga Newsdesk
Tuesday, October 31, 2023
HC Wainwright & Co. Maintains Buy on Reviva P...
Benzinga Newsdesk
Monday, October 30, 2023
Analyst Assessment On Reviva Pharmaceuticals' Positive Schizophrenia Trial Data - Sees More Than 200% Upside In Stock
Vandana Singh
12 Health Care Stocks Moving In Monday's Intraday Session
Benzinga Insights
Roth MKM Reiterates Buy on Reviva Pharmaceuti...
Benzinga Newsdesk
Reviva Pharmaceuticals Holdings Shares Resume...
Benzinga Newsdesk
Reviva Pharmaceuticals shares are trading hig...
Benzinga Newsdesk
Reviva Pharmaceuticals Shares Halted On Circu...
Benzinga Newsdesk
Reviva Pharmaceuticals Shares Resume Trading
Benzinga Newsdesk
Reviva Pharmaceuticals Shares Halted On Circu...
Benzinga Newsdesk
Could This Be A Breakthrough in Mental Health? Reviva's Schizophrenia Drug Shows Promising Results In Key Trial
Vandana Singh
Reviva Pharmaceuticals Shares Resume Trade
Benzinga Newsdesk
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga Insights
Reviva Pharmaceuticals' Phase 3 RECOVER Trial...
Benzinga Newsdesk
Friday, October 27, 2023
12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga Insights
Monday, September 25, 2023
Reviva Pharmaceuticals Announced That The Las...
Benzinga Newsdesk
Wednesday, September 20, 2023
Benzinga's Top Ratings Upgrades, Downgrades For September 20, 2023
Benzinga Insights
Roth MKM Initiates Coverage On Reviva Pharmac...
Benzinga Newsdesk
Thursday, August 17, 2023
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Reviva Reports Enrollment Completion For Pivo...
Benzinga Newsdesk
Wednesday, August 16, 2023
HC Wainwright & Co. Reiterates Buy on Reviva ...
Benzinga Newsdesk
Monday, August 14, 2023
Reviva Pharmaceuticals Q2 EPS $(0.55) Misses ...
Benzinga Newsdesk
Tuesday, July 11, 2023
Reviva Pharmaceuticals Option Alert: Oct 20 $...
Charles Gross
Monday, June 26, 2023
Expert Ratings for Reviva Pharmaceuticals
Benzinga Insights
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch